{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:26:44Z","timestamp":1757622404745,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02706-8","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T18:26:24Z","timestamp":1754677584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From standardized to individualized margins for online adaptive tumor dose escalation in rectal cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"C. M.","family":"Kensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Wiersema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Betgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doenja M.J.","family":"Lambregts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrie A.M.","family":"Marijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uulke A.","family":"van der Heide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2706_CR1","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv22\u201340.","journal-title":"Ann Oncol"},{"issue":"4","key":"2706_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711\u20138.","journal-title":"Ann Surg"},{"issue":"10139","key":"2706_CR3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJ Van der Valk","year":"2018","unstructured":"Van der Valk MJ, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the international watch & wait database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537\u201345.","journal-title":"Lancet"},{"issue":"8","key":"2706_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","volume":"16","author":"AL Appelt","year":"2015","unstructured":"Appelt AL, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol. 2015;16(8):919\u201327.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2706_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","volume":"17","author":"AG Renehan","year":"2016","unstructured":"Renehan AG, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016;17(2):174\u201383.","journal-title":"Lancet Oncol"},{"issue":"9","key":"2706_CR6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","volume":"11","author":"M Maas","year":"2010","unstructured":"Maas M, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835\u201344.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2706_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","volume":"85","author":"AL Appelt","year":"2013","unstructured":"Appelt AL, et al. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiation Oncology* Biology* Phys. 2013;85(1):74\u201380.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"4","key":"2706_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","volume":"8","author":"J-P Gerard","year":"2023","unstructured":"Gerard J-P, et al. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2\u2013cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(4):356\u201367.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2706_CR9","unstructured":"NVVH. Neoadjuvante therapie bij het lokaal gevorderd rectumcarcinoom. 2022 [cited 2025 27\u2013\u20095]; Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/colorectaal_carcinoom_crc\/primaire_behandeling_rectumcarcinoom_bij_crc\/neoadjuvante_therapie_bij_het_lokaal_gevorderd_rectumcarcinoom.html"},{"key":"2706_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2019.03.016","volume":"135","author":"J Erlandsson","year":"2019","unstructured":"Erlandsson J, et al. Tumour regression after radiotherapy for rectal cancer\u2013Results from the randomised Stockholm III trial. Radiother Oncol. 2019;135:178\u201386.","journal-title":"Radiother Oncol"},{"key":"2706_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2020.09.024","volume":"154","author":"M Intven","year":"2021","unstructured":"Intven M, et al. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5 T MR-linac: clinical implementation and initial experience. Radiother Oncol. 2021;154:172\u20138.","journal-title":"Radiother Oncol"},{"key":"2706_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ctro.2019.04.001","volume":"18","author":"D Winkel","year":"2019","unstructured":"Winkel D, et al. Adaptive radiotherapy: the Elekta unity MR-linac concept. Clin Translational Radiation Oncol. 2019;18:54\u20139.","journal-title":"Clin Translational Radiation Oncol"},{"issue":"1","key":"2706_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13014-022-02079-2","volume":"17","author":"CM Kensen","year":"2022","unstructured":"Kensen CM, et al. Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer. Radiat Oncol. 2022;17(1):110.","journal-title":"Radiat Oncol"},{"issue":"6","key":"2706_CR14","doi-asserted-by":"publisher","first-page":"e065010","DOI":"10.1136\/bmjopen-2022-065010","volume":"13","author":"ME Verweij","year":"2023","unstructured":"Verweij ME, et al. Towards response adaptive radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial. BMJ Open. 2023;13(6):e065010.","journal-title":"BMJ Open"},{"key":"2706_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.radonc.2021.07.011","volume":"162","author":"H Eijkelenkamp","year":"2021","unstructured":"Eijkelenkamp H, et al. Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac. Radiother Oncol. 2021;162:150\u20135.","journal-title":"Radiother Oncol"},{"issue":"4","key":"2706_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/cancers15041009","volume":"15","author":"CM Kensen","year":"2023","unstructured":"Kensen CM, et al. Online adaptive MRI-guided radiotherapy for primary tumor and lymph node boosting in rectal cancer. Cancers. 2023;15(4):1009.","journal-title":"Cancers"},{"issue":"5","key":"2706_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ijrobp.2019.08.052","volume":"105","author":"RP van den Ende","year":"2019","unstructured":"van den Ende RP, et al. Feasibility of gold fiducial markers as a surrogate for gross tumor volume position in image-guided radiation therapy of rectal cancer. Int J Radiation Oncology* Biology* Phys. 2019;105(5):1151\u20139.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"1","key":"2706_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1088\/0031-9155\/61\/1\/1","volume":"61","author":"J-PJ Kleijnen","year":"2015","unstructured":"Kleijnen J-PJ, et al. Evolution of motion uncertainty in rectal cancer: implications for adaptive radiotherapy. Phys Med Biol. 2015;61(1):1.","journal-title":"Phys Med Biol"},{"issue":"2","key":"2706_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2009.04.022","volume":"92","author":"J Nijkamp","year":"2009","unstructured":"Nijkamp J, et al. Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. Radiother Oncol. 2009;92(2):202\u20139.","journal-title":"Radiother Oncol"},{"issue":"7","key":"2706_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/02841860802256459","volume":"47","author":"E Ippolito","year":"2008","unstructured":"Ippolito E, et al. IGRT in rectal cancer. Acta Oncol. 2008;47(7):1317\u201324.","journal-title":"Acta Oncol"},{"issue":"1","key":"2706_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13014-022-02193-1","volume":"18","author":"L Boldrini","year":"2023","unstructured":"Boldrini L, et al. Mesorectal motion evaluation in rectal cancer MR-guided radiotherapy: an exploratory study to quantify treatment margins. Radiat Oncol. 2023;18(1):4.","journal-title":"Radiat Oncol"},{"key":"2706_CR22","doi-asserted-by":"crossref","unstructured":"Arp DT et al. Individual lymph node position variation for rectal cancer patients treated with long course chemoradiotherapy. Phys Imaging Radiation Oncol, 2024: p. 100599.","DOI":"10.1016\/j.phro.2024.100599"},{"key":"2706_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3389\/fonc.2020.01328","volume":"10","author":"SR de Mol","year":"2020","unstructured":"de Mol SR, et al. The MOMENTUM study: an international registry for the evidence-based introduction of MR-guided adaptive therapy. Front Oncol. 2020;10:1328.","journal-title":"Front Oncol"},{"issue":"2","key":"2706_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41592-020-01008-z","volume":"18","author":"F Isensee","year":"2021","unstructured":"Isensee F, et al. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18(2):203\u201311.","journal-title":"Nat Methods"},{"key":"2706_CR25","doi-asserted-by":"crossref","unstructured":"Kensen CM et al. Incorporating patient-specific information for the development of rectal tumor auto-segmentation models for online adaptive magnetic resonance Image-guided radiotherapy. Phys Imaging Radiation Oncol, 2024: p. 100648.","DOI":"10.1016\/j.phro.2024.100648"},{"key":"2706_CR26","unstructured":"Nikolov S et al. Deep learning to achieve clinically applicable segmentation of head and neck anatomy for radiotherapy. arXiv preprint arXiv:1809.04430, 2018."},{"issue":"2","key":"2706_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.radonc.2015.10.030","volume":"118","author":"JPM Burbach","year":"2016","unstructured":"Burbach JPM, et al. Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer. Radiother Oncol. 2016;118(2):399\u2013407.","journal-title":"Radiother Oncol"},{"key":"2706_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phro.2019.12.001","volume":"13","author":"F Vaassen","year":"2020","unstructured":"Vaassen F, et al. Evaluation of measures for assessing time-saving of automatic organ-at-risk segmentation in radiotherapy. Phys Imaging Radiation Oncol. 2020;13:1\u20136.","journal-title":"Phys Imaging Radiation Oncol"},{"key":"2706_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.phro.2022.11.008","volume":"24","author":"TM Janssen","year":"2022","unstructured":"Janssen TM, et al. A margin recipe for the management of intra-fraction target motion in radiotherapy. Phys Imaging Radiation Oncol. 2022;24:159\u201366.","journal-title":"Phys Imaging Radiation Oncol"},{"issue":"4","key":"2706_CR30","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0360-3016(00)00518-6","volume":"47","author":"M Van Herk","year":"2000","unstructured":"Van Herk M, et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiation Oncology* Biology* Phys. 2000;47(4):1121\u201335.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"3","key":"2706_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/jmri.22696","volume":"34","author":"YC Kim","year":"2011","unstructured":"Kim YC, et al. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging. 2011;34(3):570\u20136.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"2706_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ijrobp.2010.12.063","volume":"82","author":"M Lambrecht","year":"2012","unstructured":"Lambrecht M, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiation Oncology* Biology* Phys. 2012;82(2):863\u201370.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"3","key":"2706_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.radonc.2017.12.024","volume":"126","author":"DM Lambregts","year":"2018","unstructured":"Lambregts DM, et al. Monitoring early changes in rectal tumor morphology and volume during 5 weeks of preoperative chemoradiotherapy\u2013An evaluation with sequential MRIs. Radiother Oncol. 2018;126(3):431\u20136.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2706_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.radonc.2018.06.019","volume":"128","author":"C Fiorino","year":"2018","unstructured":"Fiorino C, et al. A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Radiother Oncol. 2018;128(3):564\u20138.","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02706-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02706-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02706-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:39:55Z","timestamp":1757360395000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02706-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2706"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02706-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"type":"electronic","value":"1748-717X"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UAH, CAMM and TMJ report institutional funding by Elekta AB. UAH reports research support by Elekta AB and research support by Philips Healthcare. The remaining authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was obtained from the Medical Ethics Committee of the Netherlands Cancer Institute in accordance with the declaration of Helsinki and all patients provided written informed consent for use of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"125"}}